FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Feb 25, 2016
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on February 25, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bausch & Lomb Incorporated
- Inspection Date
- February 25, 2016
- Product Type
- Drugs
View Company Profile
ID · c4507f5c-523b-4612-b91a-4d216108152b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 967714
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Florida District Office | |
| August 25, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 30, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 10, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 26, 2017 | VAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1304548 - 2026-03-20
- FDA Inspection 1218198 - 2023-08-25
- FDA Inspection 1082137 - 2019-01-30
- FDA Inspection 1061913 - 2018-08-10
- FDA Inspection 1015001 - 2017-05-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.